CCM
CLX icon

Coldstream Capital Management’s Clorox CLX Stock Holding History

Coldstream Capital Management’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$254K Sell
2,665
-2,294
-46% -$220K ﹤0.01% 1037
2026
Q1 		$514K Buy
4,959
+2,078
+72% +$236K 0.01% 713
2025
Q4 		$290K Sell
2,881
-14,632
-84% -$1.59M ﹤0.01% 915
2025
Q3 		$2.16M Buy
17,513
+1,292
+8% +$160K 0.03% 288
2025
Q2 		$1.95M Buy
16,221
+118
+0.7% +$15.7K 0.03% 288
2025
Q1 		$2.37M Buy
16,103
+12,214
+314% +$1.87M 0.05% 215
2024
Q4 		$632K Buy
3,889
+263
+7% +$43K 0.01% 513
2024
Q3 		$595K Buy
3,626
+2,039
+128% +$302K 0.01% 551
2024
Q2 		$217K Buy
1,587
+124
+8% +$17.2K 0.01% 912
2024
Q1 		$224K Buy
1,463
+10
+0.7% +$1.49K 0.01% 895
2023
Q4 		$207K Sell
1,453
-110
-7% -$14.7K 0.01% 886
2023
Q3 		$205K Sell
1,563
-104
-6% -$15.8K 0.01% 757
2023
Q2 		$265K Sell
1,667
-263
-14% -$42.4K 0.01% 671
2023
Q1 		$305K Sell
1,930
-3,159
-62% -$474K 0.01% 617
2022
Q4 		$714K Buy
+5,089
New +$722K 0.03% 329
2022
Q2 		$616K Buy
4,367
+255
+6% +$36.4K 0.02% 331
2022
Q1 		$572K Sell
4,112
-1,058
-20% -$162K 0.02% 340
2021
Q4 		$901K Sell
5,170
-764
-13% -$127K 0.03% 265
2021
Q3 		$1.25M Buy
5,934
+1,880
+46% +$324K 0.06% 149
2021
Q2 		$729K Sell
4,054
-5,872
-59% -$1.07M 0.03% 228
2021
Q1 		$1.91M Buy
9,926
+3,830
+63% +$737K 0.11% 102
2020
Q4 		$1.23M Buy
6,096
+886
+17% +$183K 0.07% 132
2020
Q3 		$1.09M Sell
5,210
-6
-0.1% -$1.34K 0.09% 118
2020
Q2 		$1.14M Buy
+5,216
New +$1.04M 0.1% 109

Other funds holding CLX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Coldstream Capital Management's CLX Position: Q2 2026 in Review

Coldstream Capital Management reduced its Clorox (CLX) stake by 46% in Q2 2026, selling an estimated $220K and leaving 2,665 shares worth $254K. The position accounts for ﹤0.01% of the portfolio, ranked #1037.

Coldstream Capital Management first reported a position in CLX in Q2 2020 and has held it in 24 quarters since. The position peaked at $2.37M in Q1 2025. 1,055 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Coldstream Capital Management held 2,665 shares of Clorox worth $254K as of Q2 2026.
  • Coldstream Capital Management sold 2,294 Clorox shares in Q2 2026, an estimated $220K.
  • Clorox made up ﹤0.01% of Coldstream Capital Management's portfolio in Q2 2026, its #1037 holding.
  • Coldstream Capital Management first reported a position in Clorox in Q2 2020 and has held it in 24 quarters since.
  • Coldstream Capital Management's Clorox position peaked at $2.37M in Q1 2025.
  • 1,055 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Coldstream Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.